Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome
Stock Information for The ONE Group Hospitality Inc.
Loading
Please wait while we load your information from QuoteMedia.